Home >> Marketplace Archives >> Sakura Finetek acquires Genemed, 3/16

Sakura Finetek acquires Genemed, 3/16

Print Friendly, PDF & Email


March 2016—Sakura Finetek USA announced the acquisition of Genemed Biotechnologies’ tissue-based advanced staining business for cancer detection, diagnosis, and monitoring. Genemed’s liquid-based molecular testing products were not included in the acquisition and will be spun out as an independent business. Genemed’s tissue-based advanced staining business will be integrated into Sakura Finetek with an immediate impact.

Sakura Finetek, 310-972-7800


Check Also

Sakura launches Tissue-Tek Prisma Plus

June 2018—Sakura Finetek USA launched its Tissue-Tek Prisma Plus Automated Slide Stainer, which has a throughput of 530 slides per hour.